http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03041725-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_738795713a66c3dae9a7f620c4ccb92b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a50eddfedcff205e3068561121d4bc80
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2002-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac856be506dc2e82ef31169b2925a57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75202db79c76b42c714fa592ad43acd2
publicationDate 2003-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03041725-A2
titleOfInvention Regulation of cgmp-specific phosphodiesterase 9a
abstract The invention relates to the use of PDE9A inhibitors for producing a pharmaceutical for the treatment and/or prophylaxis of coronary heart diseases, especially stable and unstable angina pectoris, acute myocardial infarction, the prophylaxis of myocardial infarction, sudden cardiac death, heart failure, and hypertension, peripheral circulatory disturbances and arteriosclerosis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8039477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8809345-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9328120-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8648085-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096603-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8431573-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3939588-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8912201-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7737156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9079905-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8623879-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7615558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8809348-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8088769-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006125554-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8623901-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9102679-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9067945-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7488733-B2
priorityDate 2001-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9929873-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4211239-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25322948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410225

Total number of triples: 57.